These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044 [TBL] [Abstract][Full Text] [Related]
3. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080 [TBL] [Abstract][Full Text] [Related]
4. Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response. Karray S; Delfraissy JF; Merle-Beral H; Wallon C; Debre P; Galanaud P J Immunol; 1988 Feb; 140(3):774-8. PubMed ID: 3257503 [TBL] [Abstract][Full Text] [Related]
5. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
8. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Kumar A; Rogers T; Maizel A; Sharma S J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611 [TBL] [Abstract][Full Text] [Related]
9. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4. Crisi GM; Katz IR; Zucker MB; Thorbecke GJ Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082 [TBL] [Abstract][Full Text] [Related]
10. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846 [TBL] [Abstract][Full Text] [Related]
11. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta. Flescher E; Fossum D; Ballester A; Maizel A; Sharma S; Talal N Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682 [TBL] [Abstract][Full Text] [Related]
12. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
13. Effects of diacetyl diamines on in vitro activation and proliferation of human B lymphocytes. Lacy J; Summers WC; Canellakis ZN J Immunol; 1985 Dec; 135(6):3772-6. PubMed ID: 3877754 [TBL] [Abstract][Full Text] [Related]
14. Human interleukin 7 is a B cell growth factor for activated B cells. Joshi PC; Choi YS Eur J Immunol; 1991 Mar; 21(3):681-6. PubMed ID: 1826263 [TBL] [Abstract][Full Text] [Related]
15. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Lasky JL; Thorbecke GJ Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT; Springgate CF; Piela TH; Choi YS J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160 [TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. Kasid A; Bell GI; Director EP J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414 [TBL] [Abstract][Full Text] [Related]
18. Human low molecular weight B cell growth factor induces surface IgM+/A- B cells to express and secrete IgA. Bertolini JN; Bertolini J; Thean E; Benson EM J Immunol; 1992 Sep; 149(5):1771-8. PubMed ID: 1506692 [TBL] [Abstract][Full Text] [Related]
19. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells. Yamashita T; Koyama J J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]